Samuel Joseph Leibovich

Samuel Joseph Leibovich

Auto-generated profile, based on publicly available information

Samuel Joseph Leibovich

University of Medicine and Dentistry of New Jersey

Research Focus & Metrics

Academic Career Length

59Years (1968-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2005 in Trends in Cell Biology
Verified
Journal Article
Closed access
PMPaul Martin
Paul Martin
SLS. Joseph Leibovich
S. Joseph Leibovich

1 October 1987 in Nature
Verified
Journal Article
Closed access
SLS. Joseph Leibovich
S. Joseph Leibovich
PPPeter J. Polverini
Peter J. Polverini
HSH. Michael Shepard
H. Michael Shepard
DWDavid Wiseman
David Wiseman
VSVera Shively
Vera Shively
NNNureddin Nuseir
Nureddin Nuseir

1 February 2012 in Advances in Wound Care
Verified
Journal Article
Closed access
CFChristopher J. Ferrante
Christopher J. Ferrante
SLSamuel Joseph Leibovich
Samuel Joseph Leibovich
Background: Macrophages (Mφs) participate in wound healing by coordinating inflammatory and angiogenic processes. Mφs respond to environmental cues by adopting either “classically” activated (M1) proinflammatory or “alternatively” activated (M2a, M2b, M2c, M2d) wound healing phenotypes. The Problem: Mφ polarization is essential for wound healing and aberrations in this process are linked to several pathologies. It is important to elucidate molecular mechanisms underlying Mφ polarization. Basic/Clinical Science Advances: Mφs are categorized as proinflammatory (M1) or anti-inflammatory/wound healing (M2). M1 Mφs are observed in initial tissue damage responses, are induced by exogenous pathogen-associated molecular patterns or endogenous damage-associated molecular patterns, and exhibit increased phagocytosis and pro-inflammatory cytokine production, facilitating innate immunity and wound debridement. M2 Mφs predominate later in repair, express vascular endothelial growth factor, transforming growth factor beta, and interleukin 10 (IL-10), are activated by varied stimuli, assist in the resolution of inflammation, and promote tissue formation and remodeling. Recent work has characterized a novel “M2d” phenotype resulting from adenosine-dependent “switching” of M1 Mφs that exhibits a pattern of marker expression that is distinct from canonical IL-4/IL-13–dependent M2a Mφs. Recent studies have demonstrated important roles for specific transcriptional elements in M1 and M2a Mφ polarization, notably members of the interferon regulatory factor family interferon regulatory factor 5 (IRF5) and IRF4, respectively. The role of these IRFs in M2d polarization and wound healing remains to be determined. Clinical Care Relevance: Knowledge of microenvironmental signals and molecular mechanisms that mediate Mφ polarization should permit their manipulation to regulate important physiological processes and resolve pathological conditions. Conclusion: Proper Mφ polarization is essential to effective wound healing, and distinct phenotypes, such as the angiogenic M2d Mφ, may be of critical importance to this process. The IRF5 transcription factor has been shown to play a key role in M1 Mφ activation and the Jumonji domain containing-3-IRF4 pathway has been implicated in M2 Mφ activation.

17 March 2013 in Inflammation
Verified
Journal Article
Closed access
PDF file
CFChristopher James Ferrante
Christopher James Ferrante
GPGrace Pinhal-Enfield
Grace Pinhal-Enfield
GEGenie Elson
Genie Elson
BCBruce Cronstein
Bruce Cronstein
GHGyorgy Hasko
Gyorgy Hasko
SLSamuel Joseph Leibovich
Samuel Joseph Leibovich

16 September 2011 in The FASEB Journal
Verified
Journal Article
Open access
PDF file
BCBalázs Csóka
Balázs Csóka
ZSZsolt Selmeczy
Zsolt Selmeczy
BKBalázs Koscsó
Balázs Koscsó
ZNZoltán H. Németh
Zoltán H. Németh
PPPal Pacher
Pal Pacher
GHGyörgy Haskó
György Haskó
Adenosine has been implicated in suppressing the proinflammatory responses of classically activated macrophages induced by Th1 cytokines. Alternative macrophage activation is induced by the Th2 cytokines interleukin (IL)‐4 and IL‐13; however, the role of adenosine in governing alternative macrophage activation is unknown. We show here that adenosine treatment of IL‐4‐ or IL‐13‐activated macrophages augments the expression of alternative macrophage markers arginase‐1, tissue inhibitor of matrix metalloproteinase‐1 (TIMP‐1), and macrophage galactose‐type C‐type lectin‐1. The stimulatory effect of adenosine required primarily A2B receptors because the nonselective adenosine receptor agonist 5'‐ N ‐ethylcarboxamidoadenosine (NECA) increased both arginase activity (EC50=261.8 nM) and TIMP‐1 production (EC50=80.67 nM), and both pharmacologic and genetic blockade of A2B receptors prevented the effect of NECA. A2A receptors also contributed to the adenosine augmentation of IL4‐induced TIMP‐1 release, as both adenosine and NECA were less efficacious in augmenting TIMP‐1 release by A2A receptor‐deficient than control macrophages. Of the transcription factors known to drive alternative macrophage activation, CCAAT‐enhancer‐binding protein β was required, while cAMP response element‐binding protein and signal transducer and activator of transcription 6 were dispensable in mediating the effect of adenosine. We propose that adenosine receptor activation suppresses inflammation and promotes tissue restitution, in part, by promoting alternative macrophage activation. Csóka, B., Selmeczy, Z., Koscsó, B., Németh, Z. H., Pacher, P., Murray, P. J., Kepka‐Lenhart, D., Morris S. M., Jr., Gause, W. C., Leibovich, S. J., Haskó, G. Adenosine promotes alternative macrophage activation via A2A and A2B receptors. FASEB J. 26, 376–386 (2012). www.fasebj.org